TJ Parker

By Jackie Rubel | September 7, 2018

TJ Parker is the co-founder and Chief Executive Officer of PillPack. He is a second generation pharmacist and holds a Doctor of Pharmacy (PharmD) degree from Massachusetts College of Pharmacy and Health Sciences. TJ was named one of Forbes’ ’30 Under 30′ in Healthcare in 2015 and Inc Magazine’s ‘30 under 30’ “Most Dynamic Young CEOs in America” in 2016.

Posted in Uncategorized

The Scope of Things: Raising the Bar for Evidence Generation in Clinical Research

Clinical Research News | As clinical research faces mounting pressure to generate real-world evidence faster and more efficiently, non-interventional studies may be a useful tool to achieve this. Yet, they [...]

Trendspotting: Embracing AI, DEI Changes, Restrategizing Research Sites

Clinical Research News | To kick off 2026, we spoke with industry experts and leaders in the Clinical Research News community about what they expect and look forward to in [...]

Clinical Research News | In clinical research, AI was the hottest topic this year, with the Food & Drug Administration, big pharma, and researchers exploring ways generative AI can help [...]

Follow the Money: AL Amyloidosis Trial, Cancer Medicine Programs, Focal Refractory Epilepsy Treatment

Clinical Research News | Protego Biopharma will advance their lead candidate, PROT-001, into a pivotal clinical trial for AL amyloidosis; BlossomHill will expand their cancer medicine programs; EpilepsyGTx will advance [...]

New Members at NORD, Pangea, AstraZeneca Collaboration, Predicting Human Toxicity

Clinical Research News | The National Organization for Rare Disorders (NORD) adds seven new members its national NORD Rare Disease Centers of Excellence Network; Pangaea announces a multi‑year strategic collaboration [...]